Author:
Xu Yan,Chen Jia,Zhou Honghui
Publisher
Springer International Publishing
Reference110 articles.
1. Actemra (tocilizumab) (2021) US prescribing information. Genentech Inc., South San Francisco, CA
2. Adbry (tralokinumab-idrm) (2022) US prescribing information In: LEO Pharma Inc., Madison, NJ
3. Adedokun OJ, Xu Z, Marano CW et al (2017) Pharmacokinetics and exposure-response relationship of golimumab in patients with moderately-to-severely active ulcerative colitis: results from phase 2/3 PURSUIT induction and maintenance studies. J Crohns Colitis 11:35–46
4. Airoldi I, Di Carlo E, Cocco C et al (2005) Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. Blood 106:3846–3853
5. Anders HJ, Saxena R, Zhao MH et al (2020) Lupus nephritis. Nat Rev Dis Primers 6(1):7